GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PharmChem Inc (OTCPK:PCHM) » Definitions » Asset Turnover

PharmChem (PharmChem) Asset Turnover : 0.48 (As of Sep. 2023)


View and export this data going back to 2003. Start your Free Trial

What is PharmChem Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. PharmChem's Revenue for the three months ended in Sep. 2023 was $1.56 Mil. PharmChem's Total Assets for the quarter that ended in Sep. 2023 was $3.25 Mil. Therefore, PharmChem's Asset Turnover for the quarter that ended in Sep. 2023 was 0.48.

Asset Turnover is linked to ROE % through Du Pont Formula. PharmChem's annualized ROE % for the quarter that ended in Sep. 2023 was 34.72%. It is also linked to ROA % through Du Pont Formula. PharmChem's annualized ROA % for the quarter that ended in Sep. 2023 was 27.43%.


PharmChem Asset Turnover Historical Data

The historical data trend for PharmChem's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmChem Asset Turnover Chart

PharmChem Annual Data
Trend Dec93 Dec94 Dec95 Dec96 Dec97 Dec98 Dec99 Dec00 Dec01 Dec02
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.95 1.89 1.51 1.31 1.18

PharmChem Quarterly Data
Jun99 Sep99 Dec99 Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Sep22 Sep23
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.35 0.36 0.08 0.48

Competitive Comparison of PharmChem's Asset Turnover

For the Diagnostics & Research subindustry, PharmChem's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmChem's Asset Turnover Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PharmChem's Asset Turnover distribution charts can be found below:

* The bar in red indicates where PharmChem's Asset Turnover falls into.



PharmChem Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

PharmChem's Asset Turnover for the fiscal year that ended in Dec. 2002 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2002 )/( (Total Assets (A: Dec. 2001 )+Total Assets (A: Dec. 2002 ))/ count )
=30.085/( (28.497+22.667)/ 2 )
=30.085/25.582
=1.18

PharmChem's Asset Turnover for the quarter that ended in Sep. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Sep. 2023 )/( (Total Assets (Q: Sep. 2022 )+Total Assets (Q: Sep. 2023 ))/ count )
=1.564/( (0+3.252)/ 1 )
=1.564/3.252
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


PharmChem  (OTCPK:PCHM) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

PharmChem's annulized ROE % for the quarter that ended in Sep. 2023 is

ROE %**(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=0.892/2.569
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(0.892 / 6.256)*(6.256 / 3.252)*(3.252/ 2.569)
=Net Margin %*Asset Turnover*Equity Multiplier
=14.26 %*1.9237*1.2659
=ROA %*Equity Multiplier
=27.43 %*1.2659
=34.72 %

Note: The Net Income data used here is four times the quarterly (Sep. 2023) net income data. The Revenue data used here is four times the quarterly (Sep. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

PharmChem's annulized ROA % for the quarter that ended in Sep. 2023 is

ROA %(Q: Sep. 2023 )
=Net Income/Total Assets
=0.892/3.252
=(Net Income / Revenue)*(Revenue / Total Assets)
=(0.892 / 6.256)*(6.256 / 3.252)
=Net Margin %*Asset Turnover
=14.26 %*1.9237
=27.43 %

Note: The Net Income data used here is four times the quarterly (Sep. 2023) net income data. The Revenue data used here is four times the quarterly (Sep. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


PharmChem Asset Turnover Related Terms

Thank you for viewing the detailed overview of PharmChem's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmChem (PharmChem) Business Description

Traded in Other Exchanges
N/A
Address
2411 E. Loop 820 N, Fort Worth, TX, USA, 76118
PharmChem Inc is engaged in selling and distributing of the PharmChek Sweat Patch Device. PharmChek is a system that uses sweat to detect the presence of illegal drugs. It consists of a transparent polyurethane outer covering, a small absorbent pad, and a release liner. Geographically the activities are carried out throughout the United States.
Executives
Alto Investors Palo 10 percent owner 470 UNIVERSITY AVENUE, PALO ALTO CA 94301
Micro Cap Partners Lp 10 percent owner

PharmChem (PharmChem) Headlines

From GuruFocus

PharmChem (PCHM) Announces Response To Opposition

By PRNewswire PRNewswire 08-11-2021